Control of autophagic cell death by caspase-10 in multiple myeloma

Cancer Cell

Volumn 23, Issue 4, 2013, Pages 435-449

  Lamy, Laurence ^a   Ngo, Vu N ^a   Emre, N C Tolga ^a   Shaffer, Arthur L ^a   Yang, Yandan ^a   Tian, Erming ^b   Nair, Vinod ^c   Kruhlak, Michael J ^a   Zingone, Adriana ^a   Landgren, Ola ^a   Staudt, Louis M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; BINDING PROTEIN; CASPASE 10; FLICE INHIBITORY PROTEIN; INTERFERON REGULATORY FACTOR 4; PROTEIN BCL 2; PROTEIN BCLAF1; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE FUNCTION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE;

EID: 84876388556     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2013.02.017     Document Type: Article

References (42)

1. Bell B.D., Leverrier S., Weist B.M., Newton R.H., Arechiga A.F., Luhrs K.A., Morrissette N.S., Walsh C.M. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc. Natl. Acad. Sci. USA 2008, 105:16677-16682.
2. Budd R.C., Yeh W.C., Tschopp J. cFLIP regulation of lymphocyte activation and development. Nat. Rev. Immunol. 2006, 6:196-204.
3. Chaudhary P.M., Eby M.T., Jasmin A., Kumar A., Liu L., Hood L. Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene 2000, 19:4451-4460.
4. Chun H.J., Zheng L., Ahmad M., Wang J., Speirs C.K., Siegel R.M., Dale J.K., Puck J., Davis J., Hall C.G., et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002, 419:395-399.
5. Galluzzi L., Vitale I., Abrams J.M., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., Dawson T.M., Dawson V.L., El-Deiry W.S., Fulda S., et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012, 19:107-120.
6. Green D.R., Oberst A., Dillon C.P., Weinlich R., Salvesen G.S. RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts. Mol. Cell 2011, 44:9-16.
7. Gutiérrez N.C., Ocio E.M., de Las Rivas J., Maiso P., Delgado M., Fermiñán E., Arcos M.J., Sánchez M.L., Hernández J.M., San Miguel J.F. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia 2007, 21:541-549.
8. Hetz C., Glimcher L.H. Fine-tuning of the unfolded protein response: Assembling the IRE1alpha interactome. Mol. Cell 2009, 35:551-561.
9. Hideshima T., Anderson K.C. Molecular mechanisms of novel therapeutic approaches for multiple myeloma. Nat. Rev. Cancer 2002, 2:927-937.
10. Hoang B., Benavides A., Shi Y., Frost P., Lichtenstein A. Effect of autophagy on multiple myeloma cell viability. Mol. Cancer Ther. 2009, 8:1974-1984.
11. Hubbard V.M., Valdor R., Patel B., Singh R., Cuervo A.M., Macian F. Macroautophagy regulates energy metabolism during effector T cell activation. J. Immunol. 2010, 185:7349-7357.
12. Hundeshagen P., Hamacher-Brady A., Eils R., Brady N.R. Concurrent detection of autolysosome formation and lysosomal degradation by flow cytometry in a high-content screen for inducers of autophagy. BMC Biol. 2011, 9:38.
13. Iwamoto M., Björklund T., Lundberg C., Kirik D., Wandless T.J. A general chemical method to regulate protein stability in the mammalian central nervous system. Chem. Biol. 2010, 17:981-988.
14. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E., Ohsumi Y., Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19:5720-5728.
15. Kasof G.M., Goyal L., White E. Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins. Mol. Cell. Biol. 1999, 19:4390-4404.
16. Kimura S., Noda T., Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 2007, 3:452-460.
17. Kuehl W.M., Bergsagel P.L. Molecular pathogenesis of multiple myeloma and its premalignant precursor. J. Clin. Invest. 2012, 122:3456-3463.
18. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
19. Luo J., Solimini N.L., Elledge S.J. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009, 136:823-837.
20. Maiuri M.C., Criollo A., Tasdemir E., Vicencio J.M., Tajeddine N., Hickman J.A., Geneste O., Kroemer G. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 2007, 3:374-376.
21. McPherson J.P., Sarras H., Lemmers B., Tamblyn L., Migon E., Matysiak-Zablocki E., Hakem A., Azami S.A., Cardoso R., Fish J., et al. Essential role for Bclaf1 in lung development and immune system function. Cell Death Differ. 2009, 16:331-339.
22. McStay G.P., Salvesen G.S., Green D.R. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ. 2008, 15:322-331.
23. Ngo V.N., Davis R.E., Lamy L., Yu X., Zhao H., Lenz G., Lam L.T., Dave S., Yang L., Powell J., Staudt L.M. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 2006, 441:106-110.
24. Ogata M., Hino S., Saito A., Morikawa K., Kondo S., Kanemoto S., Murakami T., Taniguchi M., Tanii I., Yoshinaga K., et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol. Cell. Biol. 2006, 26:9220-9231.
25. Pankiv S., Clausen T.H., Lamark T., Brech A., Bruun J.A., Outzen H., Øvervatn A., Bjørkøy G., Johansen T. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 2007, 282:24131-24145.
26. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., Packer M., Schneider M.D., Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
27. Pengo N., Scolari M., Oliva L., Milan E., Mainoldi F., Raimondi A., Fagioli C., Merlini A., Mariani E., Pasqualetto E., et al. Plasma cells require autophagy for sustainable immunoglobulin production. Nat. Immunol. 2013, 14:298-305.
28. Rabinowitz J.D., White E. Autophagy and metabolism. Science 2010, 330:1344-1348.
29. Rawlings N.D., Tolle D.P., Barrett A.J. MEROPS: the peptidase database. Nucleic Acids Res. 2004, 32(Database issue):D160-D164.
30. Reggiori F., Klionsky D.J. Autophagy in the eukaryotic cell. Eukaryot. Cell 2002, 1:11-21.
31. Rénert A.F., Leprince P., Dieu M., Renaut J., Raes M., Bours V., Chapelle J.P., Piette J., Merville M.P., Fillet M. The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells. J. Proteome Res. 2009, 8:4810-4822.
32. Salmena L., Lemmers B., Hakem A., Matysiak-Zablocki E., Murakami K., Au P.Y., Berry D.M., Tamblyn L., Shehabeldin A., Migon E., et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 2003, 17:883-895.
33. Sarras H., Alizadeh Azami S., McPherson J.P. In search of a function for BCLAF1. ScientificWorldJournal 2010, 10:1450-1461.
34. Shaffer A.L., Emre N.C., Lamy L., Ngo V.N., Wright G., Xiao W., Powell J., Dave S., Yu X., Zhao H., et al. IRF4 addiction in multiple myeloma. Nature 2008, 454:226-231.
35. Shimizu S., Kanaseki T., Mizushima N., Mizuta T., Arakawa-Kobayashi S., Thompson C.B., Tsujimoto Y. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell Biol. 2004, 6:1221-1228.
36. Wachmann K., Pop C., van Raam B.J., Drag M., Mace P.D., Snipas S.J., Zmasek C., Schwarzenbacher R., Salvesen G.S., Riedl S.J. Activation and specificity of human caspase-10. Biochemistry 2010, 49:8307-8315.
37. Walsh J.G., Logue S.E., Lüthi A.U., Martin S.J. Caspase-1 promiscuity is counterbalanced by rapid inactivation of processed enzyme. J. Biol. Chem. 2011, 286:32513-32524.
38. Wang J., Zheng L., Lobito A., Chan F.K., Dale J., Sneller M., Yao X., Puck J.M., Straus S.E., Lenardo M.J. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999, 98:47-58.
39. Wang J., Chun H.J., Wong W., Spencer D.M., Lenardo M.J. Caspase-10 is an initiator caspase in death receptor signaling. Proc. Natl. Acad. Sci. USA 2001, 98:13884-13888.
40. Wilson N.S., Dixit V., Ashkenazi A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat. Immunol. 2009, 10:348-355.
41. Yang Y., Shaffer A.L., Emre N.C., Ceribelli M., Zhang M., Wright G., Xiao W., Powell J., Platig J., Kohlhammer H., et al. Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell. 2012, 21:723-737.
42. Yu L., Alva A., Su H., Dutt P., Freundt E., Welsh S., Baehrecke E.H., Lenardo M.J. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304:1500-1502.